PL2340872T3 - Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności - Google Patents

Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności

Info

Publication number
PL2340872T3
PL2340872T3 PL11002406T PL11002406T PL2340872T3 PL 2340872 T3 PL2340872 T3 PL 2340872T3 PL 11002406 T PL11002406 T PL 11002406T PL 11002406 T PL11002406 T PL 11002406T PL 2340872 T3 PL2340872 T3 PL 2340872T3
Authority
PL
Poland
Prior art keywords
insomnia
treatment
pharmaceutical formulations
new pharmaceutical
formulations useful
Prior art date
Application number
PL11002406T
Other languages
English (en)
Inventor
Anders Pettersson
Christer Nyström
Susanne Bredenberg
Original Assignee
Orexo Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orexo Ab filed Critical Orexo Ab
Publication of PL2340872T3 publication Critical patent/PL2340872T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL11002406T 2004-10-27 2005-10-26 Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności PL2340872T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0423800.2A GB0423800D0 (en) 2004-10-27 2004-10-27 New pharmaceutical formulations
EP05798488.2A EP1807156B1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia
EP11002406.4A EP2340872B1 (en) 2004-10-27 2005-10-26 New pharmaceutical formulations useful in the treatment of insomnia

Publications (1)

Publication Number Publication Date
PL2340872T3 true PL2340872T3 (pl) 2017-12-29

Family

ID=33515600

Family Applications (2)

Application Number Title Priority Date Filing Date
PL11002406T PL2340872T3 (pl) 2004-10-27 2005-10-26 Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności
PL05798488T PL1807156T3 (pl) 2004-10-27 2005-10-26 Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL05798488T PL1807156T3 (pl) 2004-10-27 2005-10-26 Nowe preparaty farmaceutyczne użyteczne w leczeniu bezsenności

Country Status (13)

Country Link
US (4) US9265720B2 (pl)
EP (2) EP1807156B1 (pl)
JP (1) JP5064226B2 (pl)
CY (2) CY1118414T1 (pl)
DK (2) DK1807156T3 (pl)
ES (1) ES2610469T3 (pl)
GB (1) GB0423800D0 (pl)
HU (1) HUE030609T2 (pl)
LT (2) LT1807156T (pl)
PL (2) PL2340872T3 (pl)
PT (2) PT1807156T (pl)
SI (2) SI1807156T1 (pl)
WO (1) WO2006046041A1 (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070030178A (ko) 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
BRPI0609984A2 (pt) * 2005-05-25 2010-05-18 Transcept Pharmaceuticals Inc uso de zolpidem ou um sal do mesmo
US20070287740A1 (en) 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
WO2008075372A1 (en) * 2006-12-18 2008-06-26 Lupin Limited Controlled release dosage forms of zolpidem
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
EP2299982B1 (de) * 2008-06-20 2018-04-04 Merck Patent GmbH Direkt verpressbare und schnell zerfallende tablettenmatirx
EP2437730A4 (en) * 2009-05-20 2014-02-26 Lingual Consegna Pty Ltd ORAL AND / OR SUBLINGUAL THERAPEUTIC FORMULATION
CN105581991A (zh) * 2015-12-28 2016-05-18 安徽省逸欣铭医药科技有限公司 一种酒石酸唑吡坦舌下片及其制备方法
GEAP202215600A (en) 2018-10-08 2022-10-25 Troikaa Pharmaceuticals Ltd Oromucosal solutions of zolpidem or pharmaceutically acceptable salts thereof
CN111939133A (zh) * 2019-05-16 2020-11-17 鲁南制药集团股份有限公司 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK152744C (da) 1982-08-13 1988-10-31 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat
SE8800080L (sv) 1988-01-13 1989-07-14 Kabivitrum Ab Laekemedelskomposition
SE8803935L (sv) 1988-10-31 1990-05-01 Kabivitrum Ab Laekemedelskomposition
JPH0665103A (ja) * 1992-08-13 1994-03-08 ▲寛▼治 ▲高▼田 向精神薬のための速吸収性舌下投与製剤
US7632517B2 (en) 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US6200604B1 (en) 1998-03-27 2001-03-13 Cima Labs Inc. Sublingual buccal effervescent
SE9803240D0 (sv) 1998-09-24 1998-09-24 Diabact Ab A pharmaceutical composition having a rapid action
SE9803239D0 (sv) 1998-09-24 1998-09-24 Diabact Ab Composition for the treatment of acute pain
EP1005863A1 (en) 1998-12-04 2000-06-07 Synthelabo Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
WO2001030391A2 (en) * 1999-10-27 2001-05-03 Farmarc Nederland Bv Pharmaceutical composition containing midazolam
WO2001078725A2 (en) 2000-04-13 2001-10-25 Synthon B.V. Modified release formulations containing a hypnotic agent
CN1290525A (zh) 2000-10-10 2001-04-11 北京万全阳光医药科技有限公司 冷冻干燥的扎来普隆速溶口服组合物
US20040176359A1 (en) 2001-02-20 2004-09-09 University Of Kentucky Research Foundation Intranasal Benzodiazepine compositions
US20030035839A1 (en) 2001-05-15 2003-02-20 Peirce Management, Llc Pharmaceutical composition for both intraoral and oral administration
DE60228703D1 (de) * 2001-05-24 2008-10-16 Alexza Pharmaceuticals Inc Verabreichung von sedativa-hypnotika durch inhalation
WO2003059349A1 (en) * 2002-01-10 2003-07-24 Biovail Laboratories Inc. Sedative non-benzodiazepine formulations
AU2003221326A1 (en) 2002-03-06 2003-09-16 Kyowa Hakko Kogyo Co., Ltd. Tablets quickly disintegrating in oral cavity
ES2199061B1 (es) 2002-06-10 2005-02-16 Laboratorios Vita, S.A. Comprimidos bucodispersables y procedimiento para su obtencion.
EP1552851A1 (en) 2002-06-10 2005-07-13 Dainippon Pharmaceutical Co., Ltd. Rapidly disintegrating tablet and process for producing the same
US20050038042A1 (en) * 2002-11-15 2005-02-17 Jenet Codd Modified release composition comprising a short-acting hypnotic for treatment of sleep disorders
CN1418631A (zh) 2002-12-19 2003-05-21 王登之 治疗失眠的佐匹克隆口腔崩解片及其制备方法
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
JP4739217B2 (ja) * 2003-05-07 2011-08-03 サムヤン コーポレイション 速く溶ける錠剤を製造するための高可塑性顆粒
US20050215521A1 (en) * 2003-12-22 2005-09-29 Karim Lalji Modafinil combination therapy for improving sleep quality
KR20070030178A (ko) * 2004-02-17 2007-03-15 트랜스오랄 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의사용 방법
NZ548856A (en) 2004-02-17 2009-10-30 Transcept Pharmaceuticals Inc Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
CN1290525C (zh) * 2004-07-13 2006-12-20 赵余庆 一种降血糖的植物提取物及其用途

Also Published As

Publication number Publication date
DK2340872T3 (en) 2017-09-18
LT1807156T (lt) 2016-12-12
WO2006046041A1 (en) 2006-05-04
EP2340872B1 (en) 2017-07-05
SI1807156T1 (sl) 2017-01-31
CY1119580T1 (el) 2018-03-07
US9265720B2 (en) 2016-02-23
US20130230589A1 (en) 2013-09-05
GB0423800D0 (en) 2004-12-01
US20080311208A1 (en) 2008-12-18
DK1807156T3 (en) 2017-01-23
JP5064226B2 (ja) 2012-10-31
US9597281B2 (en) 2017-03-21
PT2340872T (pt) 2017-10-06
ES2610469T3 (es) 2017-04-27
SI2340872T1 (sl) 2017-10-30
US20120277261A1 (en) 2012-11-01
HUE030609T2 (en) 2017-05-29
LT2340872T (lt) 2017-09-11
JP2008517988A (ja) 2008-05-29
US20110268796A1 (en) 2011-11-03
CY1118414T1 (el) 2017-06-28
PL1807156T3 (pl) 2017-06-30
EP1807156A1 (en) 2007-07-18
PT1807156T (pt) 2017-01-19
EP2340872A1 (en) 2011-07-06
EP1807156B1 (en) 2016-10-12

Similar Documents

Publication Publication Date Title
IL185462A0 (en) New pharmaceutical compositions useful in the treatment of pain
EP1758595A4 (en) Use of lipid conjugates in the treatment of diseases
IL178775A (en) Pharmaceuticals containing glucocorticoid for use in the treatment of disorders requiring acute glucocorticoid therapy
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL183101A (en) Use of tetrahydrocannabivarin in drug production
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
IL180078A (en) Derivatives of 9-cis retinal for use in treating deficiency of 11-cis retinal
GB0324761D0 (en) Use of compounds in therapy
IL172316A0 (en) Novel compounds and their use in therapy
GB0523576D0 (en) Drug composition and its use in therapy
IL212214A0 (en) Use of lipid conjugates in the treatment of disease
PT2340872T (pt) Novas formulações farmacêuticas úteis no tratamento de insónia
IL183893A0 (en) Pharmaceutical compositions for the treatment of cellulite
EP1757282A4 (en) USE OF KAURANE COMPOUNDS IN THE MANUFACTURE OF MEDICAMENTS
PL1803456T3 (pl) Kompozycje farmaceutyczne zawierające L-733060 do zastosowania w leczeniu guzów nowotworowych
GB0312844D0 (en) Use of compounds in medicine
GB0406014D0 (en) Pharmaceutical composition and use
EP1956001A4 (en) PHARMACEUTICAL PRODUCT FOR USE IN THE TREATMENT OF URETEROLITHIASE
IL174968A0 (en) The use of ifenprodil in the treatment of pain
HK1110217A (en) New pharmaceutical compositions useful in the treatment of pain
ZA200704859B (en) Pharmaceutical compositions for the treatment of cellulite
GB0305969D0 (en) Improvements in the formulation of medicaments
IL229980A0 (en) Use of fatty conjugates to treat diseases
IL229982A0 (en) Use of fatty conjugates to treat diseases
IL229981A0 (en) Use of fatty conjugates to treat diseases